Chipscreen Biosciences Ltd is a leading China-based biotech company that specializes in discovering and developing proprietary small molecule therapeutics for unmet medical needs. The company is utilizing its proprietary chemical genomics-based discovery platform to develop a portfolio of clinical and preclinical stage programs in a number of therapeutic areas. Our core competence is the science-driven approach in discovery, strong pipeline building capability, experience with IP, and regulatory expertise. ? Chipscreen was founded in March 2001 by several highly regarded Chinese returnees from the United States with academic, scientific, and industrial experience.